In both the medical technology and food industry, the demand for plastics that meet the strictest regulations and exhibit high performance with low toxicity is increasing. The MARFRAN® and MARFRAN.MED® product ranges developed by FFE combine established processing methods with approaches that meet the new challenges. As a result, they can be used as an effective replacement for vulcanized rubber and PVC.

MARFRAN.MED® and halogen-free MARFRAN.MED® AU compounds are ideal for products that require maximum safety and performance, particularly in the medical care sector. They have an antimicrobial effect and thus prevent the multiplication of microbes on the surfaces of the end products. The patented compounds contain usnic acid, an antibacterial substance naturally occurring in various lichen species. Its effect on bacteria such as Staphylococcus, Streptococcus, Pneumococcus and Mycobacterium tuberculosis is particularly significant. Marfran.Med® AU was proven to be effective in its antimicrobial performance, especially against gram-positive bacteria (99.9% effective) according to the ASTME2180-07 test. The manufacturing process is carried out in accordance with ISO 13485 in a clean room of the ISO 7 class according to ISO 14644-1, which corresponds to the clean room class 10,000 according to US FED STD 209E.

With the development of MARFRAN.MED® GL and MARFRAN.MED® GLE, FFE has succeeded in developing solvent-bondable compounds (solvents cyclohexanone and THF), e.g. for bonding with PC or ABS, which are both frequently used for infusion systems. The compounds are transparent and can be used for injection molding as well as extrusion. Bonding with solvents produces no chemical residues, as the solvents used completely evaporate and ensure a clean bond. With the MARFRAN.MED® series,FFE provides solutions for the safe production of infusion sets and other medical applications such as tubes for peristaltic pumps, catheter systems or respirators.